SCHEMBL7006753

SCHEMBL7006753

CC=CC(CCC)OC(C)=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.34
CHRM1 P11229 2/20 0.32
AKR1A1 P14550 1/20 0.32
CHRM3 P20309 1/20 0.32
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32
ADRA1A P35348 1/20 0.32
HRH1 P35367 1/20 0.32
DRD3 P35462 1/20 0.32
SLC6A3 Q01959 1/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC2 Q92769 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
GALR3 O60755 2/20 0.32
CHRM2 P08172 1/20 0.31
CHRM4 P08173 1/20 0.31
TBXA2R P21731 1/20 0.31
CYP3A4 P08684 2/20 0.31
NFKB1 P19838 2/20 0.31
NPSR1 Q6W5P4 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7006751 1.00 TSHR (0.34) TSHRCHRM1AKR1A1CHRM3HTR2A
SCHEMBL29275508 0.89 GALR3 (0.37) GALR3PDE4DALDH1A1CTSK
SCHEMBL28655932 0.88 TSHR (0.33) TSHRCHRM1GALR3CHRM2CHRM4
SCHEMBL11516139 0.87 GALR3 (0.41) GALR3PDE4DMAPT
SCHEMBL11516146 0.87 GALR3 (0.41) GALR3PDE4DMAPT
SCHEMBL4258145 0.83 TSHR (0.37) TSHRCHRM1TDP1GALR3CHRM2
SCHEMBL4258148 0.83 TSHR (0.37) TSHRCHRM1TDP1GALR3CHRM2
SCHEMBL31534046 0.83 TSHR (0.37) TSHRCHRM1TDP1GALR3CHRM2
SCHEMBL14224898 0.82 TSHR (0.33) TSHRCHRM1AKR1A1CHRM3HTR2A
SCHEMBL11490193 0.79 USP2 (0.40) TSHRCYP3A4MAPTSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1335918-A1 NOVEL COMPOUNDS AstraZeneca AB (SE) 2003-08-20 EP disclosed
WO-2002038571-A1 NOVEL COMPOUNDS ASTRAZENECA AB (SE) 2002-05-16 WO disclosed